Transient congenital hypothyroidism due to maternal factor Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Transient congenital hypothyroidism due to maternal factor.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

Clotic

Laboratorios Salvat, S.A.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Clotic

(clotrimazole)Orphan drug

Laboratorios Salvat, S.A.

Azole Antifungal [EPC]

12.1 Mechanism of Action Clotrimazole is an azole antifungal agent [see Microbiology (12.4) ] .

Approved Sep 2025FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Transient congenital hypothyroidism due to maternal factor.
Search all trials →

Search clinical trials for Transient congenital hypothyroidism due to maternal factor →

Recent News & Research

No recent news articles indexed yet for Transient congenital hypothyroidism due to maternal factor.
Search PubMed for Transient congenital hypothyroidism due to maternal factor →

Browse all Transient congenital hypothyroidism due to maternal factor news →

Specialist Network

No specialists currently listed for Transient congenital hypothyroidism due to maternal factor.

View all Transient congenital hypothyroidism due to maternal factor specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰